Scott A. Flanders, M.D. is currently Chief Clinical Strategy Officer for Michigan Medicine, where in partnership with the Chief Strategy Officer, he is responsible for developing and operationalizing Michigan Medicine’s growing statewide network. Dr. Flanders is a Professor of Medicine in the Division of Hospital Medicine at the University of Michigan, where he serves as Vice Chair for the Department of Internal Medicine. He was the founding leader of Michigan’s Hospital Medicine Program, and from 2003-2017 grew the program from four faculty to over 100, while concurrently developing robust clinical, educational, quality and research programs within the section. Dr. Flanders was a founding member of the Board of Directors of the Society of Hospital Medicine (SHM) and is a Past-President of SHM. In 2013, Dr. Flanders was awarded the designation of Master in Hospital Medicine by the Society of Hospital Medicine. Dr. Flanders’ research interests include hospitalists, hospital-acquired conditions and their prevention, dissemination of patient safety and quality improvement practices, and the diagnosis and treatment of lower respiratory infections. Dr. Flanders developed and leads the Michigan Hospital Medicine Safety (HMS) Consortium, focused on preventing adverse events in hospitalized patients. He has authored over 150 journal articles and book chapters, and has edited two textbooks and a book series in the field of Hospital Medicine. Dr. Flanders received his Medical Degree from the University of Chicago Pritzker School of Medicine and completed his residency and chief residency at the University of California, San Francisco.